BMC oral health · 2026
Systemic non-steroidal anti-inflammatory drugs as adjuncts in the treatment of chronic periodontitis: a systematic review and network meta-analysis.
СтатьяСистематический обзорNetwork Meta-AnalysisНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Li Juan, Xie Pengxian, Peng Wei
Аннотация
OBJECTIVES: Systematically evaluate the clinical efficacy of systemically administered non-steroidal anti-inflammatory drugs (NSAIDs) as an adjunct to scaling and root planing (SRP) for periodontitis, assess the therapeutic effects of different drugs, and identify the most effective treatment regimen.
MATERIALS AND METHODS: This study is registered in PROSPERO under trial No. CRD420250651756. Randomized controlled trials (RCTs) examining systemic NSAIDs as SRP adjuncts were identified through systematic searches of PubMed, Embase, Web of Science, Cochrane Library and CNKI databases. Eligible studies were screened, followed by data extraction and risk-of-bias assessment using Cochrane criteria. Efficacy was assessed through changes in probing depth (PD) and clinical attachment loss (CAL). Statistical analyses were performed using Stata 18.0, and R 4.4.3 software.
RESULTS: Thirteen RCTs involving 549 patients met inclusion criteria. The results of the Network meta-analysis (NMA) identified that, when NSAIDs are used as an adjuvant treatment for periodontitis, compared with using only SRP to treat periodontitis, ibuprofen + SRP [MD = 0.58, 95% CI (0.31, 0.85)] shows the most significant efficacy in improving PD and CAL after 1 - month follow - up. At 3 months, the ibuprofen-doxycycline combination [MD = 1.70, 95% CI (1.16, 2.24)] and omega-3 polyunsaturated fatty acids (PUFAs) combined with aspirin [MD = 0.82, 95% CI (0.57, 1.07)] demonstrated superior efficacy versus monotherapies.
CONCLUSIONS: Current evidence suggests that systemic administration of NSAIDs as an adjunct to periodontal baseline therapy may provide clinically significant benefits in periodontitis management. However, further well-designed randomized controlled trials with larger sample sizes are required to validate and refine this conclusion.
MATERIALS AND METHODS: This study is registered in PROSPERO under trial No. CRD420250651756. Randomized controlled trials (RCTs) examining systemic NSAIDs as SRP adjuncts were identified through systematic searches of PubMed, Embase, Web of Science, Cochrane Library and CNKI databases. Eligible studies were screened, followed by data extraction and risk-of-bias assessment using Cochrane criteria. Efficacy was assessed through changes in probing depth (PD) and clinical attachment loss (CAL). Statistical analyses were performed using Stata 18.0, and R 4.4.3 software.
RESULTS: Thirteen RCTs involving 549 patients met inclusion criteria. The results of the Network meta-analysis (NMA) identified that, when NSAIDs are used as an adjuvant treatment for periodontitis, compared with using only SRP to treat periodontitis, ibuprofen + SRP [MD = 0.58, 95% CI (0.31, 0.85)] shows the most significant efficacy in improving PD and CAL after 1 - month follow - up. At 3 months, the ibuprofen-doxycycline combination [MD = 1.70, 95% CI (1.16, 2.24)] and omega-3 polyunsaturated fatty acids (PUFAs) combined with aspirin [MD = 0.82, 95% CI (0.57, 1.07)] demonstrated superior efficacy versus monotherapies.
CONCLUSIONS: Current evidence suggests that systemic administration of NSAIDs as an adjunct to periodontal baseline therapy may provide clinically significant benefits in periodontitis management. However, further well-designed randomized controlled trials with larger sample sizes are required to validate and refine this conclusion.